drugset / Trial / NCT00961532

Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept

NCT00961532

NaSingle-groupOpen-labelTreatment

Summary

The investigators intend to show that DDAVP improves platelet activity from baseline to 60 minutes after treatment start.

Timeline

Start
2010-12
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Desmopressin Peptide 0.4 ug/kg Intravenous